Clin2
NCT07042672Possibly a fitRecruiting

Therapy and medication for binge eating in obesity

Binge Eating Disorder Associated With ObesityBinge Eating DisorderEating Disorder BingeEating DisordersGLP-1CBTObesity &Amp; Overweight

Treatments studied

Part of Hormones & metabolism, Mental health clinical trials.

This trial tests whether a medication (liraglutide) plus behavioral counseling helps people with severe obesity and binge-eating disorder reduce binge episodes, lose weight, and improve coping. Participants will receive either liraglutide or placebo, along with group therapy sessions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old.
  • You have severe obesity (BMI over 40, or over 35 with health problems like diabetes or high blood pressure).
  • You have been diagnosed with binge-eating disorder (BED) by a doctor.
  • You are willing to try a combination of counseling and a daily injection (liraglutide) to help with eating and weight.
  • You can speak and understand Norwegian.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07698132Recruiting
Psychotherapy for binge eating disorder

This trial tests three levels of psychotherapy (high, medium, and low intensity) to find which works best for binge eating disorder. It aims to help you stop binge episodes and improve your relationship with food.

Ballerup Municipality, Capital Region
NCT05149859Recruiting
Binge eating and severe obesity treatment after screening

This study looks at people with obesity, including those with binge eating disorder (BED). It compares groups based on their binge-eating questionnaires and tests a care approach at obesity and mental-health clinics.

Québec
NCT06847399Recruiting· Phase 2
Tirzepatide for Binge Eating Disorder

This trial tests if tirzepatide (a weekly injection) can help reduce binge eating compared to a placebo or another medication (lisdexamfetamine dimesylate). It may be a good fit for people with moderate or severe binge eating disorder who also have a high body weight.

Baltimore, Maryland
NCT05664516Recruiting· Phase 2
Oxytocin treatment study for binge eating disorder adults

This Phase 2 trial tests whether oxytocin (a hormone-like medication) can reduce binge-eating symptoms in adults with binge-eating disorder (including related conditions like bulimia or certain feeding/eating disorders). You may be eligible if your symptoms match the trial’s specific diagnosis rules and you can safely take the study medication.

Boston, Massachusetts
NCT07435974Recruiting
Online treatment for binge eating in Chile

This trial tests an online program to help adults in Chile who have frequent binge eating and are overweight. It aims to reduce binge eating and improve health without changing your current medications if they are stable.

Temuco, La Araucanía
NCT07212673Recruiting
Online therapy for binge eating disorder

This study tests a digital program that combines cognitive-behavioral therapy with mindfulness training to help people with binge eating disorder. It may help reduce binge eating episodes and improve your relationship with food.

The Bronx, New York

Hear when a new Binge Eating Disorder Associated With Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.